Daniel Gooding active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NUFORMIX PLC | Director/Board Member | - | - |
| Founder | 2007-12-31 | - | |
| Chief Executive Officer | 2007-12-31 | 2020-06-21 | |
| Chairman | 2020-02-04 | - |
Career history of Daniel Gooding
Former positions of Daniel Gooding
| Companies | Position | Start | End |
|---|---|---|---|
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2007-10-22 | 2020-05-31 |
| Chief Executive Officer | 2007-10-22 | 2020-05-31 | |
| Founder | 2007-10-22 | 2020-05-31 |
Training of Daniel Gooding
| University of Leeds | Doctorate Degree |
Statistics
International
| United Kingdom | 4 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NUFORMIX PLC | Health Technology |
| Private companies | 1 |
|---|---|
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Daniel Gooding
- Experience
